logo
#

Latest news with #HealthcareAI

Innovaccer Announces Availability of Innovaccer Gravity™ in the New AWS Marketplace AI Agents and Tools Category
Innovaccer Announces Availability of Innovaccer Gravity™ in the New AWS Marketplace AI Agents and Tools Category

Yahoo

time3 days ago

  • Business
  • Yahoo

Innovaccer Announces Availability of Innovaccer Gravity™ in the New AWS Marketplace AI Agents and Tools Category

SAN FRANCISCO, July 16, 2025--(BUSINESS WIRE)--Innovaccer Inc., a leading Healthcare AI company, today announced the availability of Innovaccer Gravity™, its Healthcare Intelligence Platform in the new AI Agents and Tools category in AWS Marketplace. This enables AWS customers to easily discover, buy, and deploy Innovaccer's Healthcare Intelligence Platform using their AWS accounts, accelerating AI agent and agentic workflow development. The AI Agents and Tools category in AWS Marketplace serves as a centralized catalog for hundreds of AI solutions from trusted AWS Partners. Gravity helps organizations activate enterprise intelligence across healthcare domains, accelerate time to value, and reduce total cost of ownership, enabling customers to modernize their AI infrastructure and deploy AI-powered solutions with ease. "By offering Gravity through the AWS Marketplace AI Agents and Tools category, we're providing customers with a streamlined way to access our Healthcare Intelligence Platform, helping them buy and deploy AI agent solutions faster and more efficiently," said Abhinav Shashank, CEO at Innovaccer. "Our customers in health systems are already using these capabilities to reduce costs, improve outcomes, and accelerate innovation, demonstrating the real-world value of Gravity." Innovaccer Gravity™ delivers essential capabilities including: Rich healthcare context including data quality rules, pre-built analytics, and end-point workflows Security and guardrails required to build and deploy AI solutions Developer Studio to rapidly build, customize, and deploy AI-powered workflows These features enable customers to unify enterprise-wide data, activate real-time insights, and activate scalable AI solutions to improve outcomes. Through the AWS Marketplace AI Agents and Tools category, customers can significantly accelerate their procurement process to drive AI innovation, reducing the time needed for vendor evaluations and complex negotiations. With centralized purchasing using AWS accounts, customers maintain visibility and control over licensing, payments, and access through AWS. Available as a SaaS solution, Innovaccer Gravity™ supports FHIR-native protocols and healthcare model context protocol (HMCP) for streamlined agent communication. This enables customers to seamlessly connect with other AWS services and flexibly deploy across their AWS environment. To learn more about Innovaccer Gravity™ in AWS Marketplace, visit Innovaccer. To learn more about the new AI Agents and Tools category in AWS Marketplace, visit About Innovaccer Innovaccer activates the flow of healthcare data, empowering providers, payers, and government organizations to deliver intelligent and connected experiences that advance health outcomes. The Healthcare Intelligence Cloud equips every stakeholder in the patient journey to turn fragmented data into proactive, coordinated actions that elevate the quality of care and drive operational performance. Leading healthcare organizations like CommonSpirit Health, Atlantic Health, and Banner Health trust Innovaccer to integrate a system of intelligence into their existing infrastructure— extending the human touch in healthcare. For more information, visit View source version on Contacts Press Contact:Arushi AwasthiInnovaccer 415-562-2139

Samurai 2K Aerosol Full Year 2025 Earnings: RM0.023 loss per share (vs RM0.005 profit in FY 2024)
Samurai 2K Aerosol Full Year 2025 Earnings: RM0.023 loss per share (vs RM0.005 profit in FY 2024)

Yahoo

time4 days ago

  • Business
  • Yahoo

Samurai 2K Aerosol Full Year 2025 Earnings: RM0.023 loss per share (vs RM0.005 profit in FY 2024)

Revenue: RM81.2m (up 1.7% from FY 2024). Net loss: RM7.81m (down from RM1.54m profit in FY 2024). RM0.023 loss per share (down from RM0.005 profit in FY 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Samurai 2K Aerosol shares are up 10% from a week ago. You should learn about the 3 warning signs we've spotted with Samurai 2K Aerosol (including 2 which are a bit concerning). Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store